VBCG
SNY icon

Valley Brook Capital Group’s Sanofi SNY Stock Holding History

Valley Brook Capital Group’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-200
Closed -$9K – 370
2021
Q1 		$9K Hold
200
– – 0.01% 372
2020
Q4 		$9K Buy
+200
New +$9.86K 0.01% 334

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Valley Brook Capital Group's SNY Position: Q2 2021 in Review

Valley Brook Capital Group sold out of Sanofi (SNY) in Q2 2021, closing a stake of 200 shares — an estimated $9K sold.

Valley Brook Capital Group first reported a position in SNY in Q4 2020 and held it in 2 quarters. The position peaked at $9K in Q1 2021. 585 funds tracked by Wall St. Rank hold SNY as of Q2 2021.

  • Valley Brook Capital Group reported no remaining Sanofi position as of Q2 2021 after selling out during the quarter.
  • Valley Brook Capital Group sold 200 Sanofi shares in Q2 2021, an estimated $9K.
  • Valley Brook Capital Group first reported a position in Sanofi in Q4 2020 and held it in 2 quarters.
  • Valley Brook Capital Group's Sanofi position peaked at $9K in Q1 2021.
  • 585 funds tracked by Wall St. Rank held Sanofi as of Q2 2021.

Based on Valley Brook Capital Group's 13F filing for Q2 2021, filed 22 Jul 2021.